1. Momenimovahed, Z, Salehiniya, H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer 2019; 11: 151–164.
Google Scholar | Medline2. Rangarajan, B, Shet, T, Wadasadawala, T, et al. Breast cancer: an overview of published Indian data. South Asian J Cancer 2016; 5: 86–92.
Google Scholar | Crossref | Medline3. Esteva, FJ, Valero, V, Pusztai, L, et al. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 2001; 6: 133–146.
Google Scholar | Crossref | Medline | ISI4. Crawford, J, Dale, DC, Lyman, GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer 2004; 100: 228–237.
Google Scholar | Crossref | Medline | ISI5. Chambers, P, Jani, Y, Wei, L, et al. Patient factors and their impact on neutropenic events: a systematic review and meta-analysis. Support Care Cancer 2019; 27: 2413–2424.
Google Scholar | Crossref | Medline6. Mehta, HM, Malandra, M, Corey, SJ. G-CSF and GM-CSF in neutropenia. J Immunol 2015; 195: 1341–1349.
Google Scholar | Crossref | Medline7. Lustberg, MB . Management of neutropenia in cancer patients. Clin Adv Hematol Oncol 2012; 10: 825–826.
Google Scholar | Medline8. Schwenkglenks, M, Pettengell, R, Jackisch, C, et al. Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study. Support Care Cancer 2011; 19: 483–490.
Google Scholar | Crossref | Medline9. Lucas, AJ, Olin, JL, Coleman, MD. Management and preventive measures for febrile neutropenia. P T 2018; 43: 228–232.
Google Scholar | Medline10. Ria, R, Reale, A, Moschetta, M, et al. Neutropenia and G-CSF in lymphoproliferative diseases. Hematology 2013; 18: 131–137.
Google Scholar | Crossref | Medline11. Gustinetti, G, Mikulska, M. Bloodstream infections in neutropenic cancer patients: a practical update. Virulence 2016 Apr 2; 7: 280–297.
Google Scholar | Crossref | Medline12. Salako, O, Okunade, KS, Adeniji, AA, et al. Chemotherapy-induced neutropenia among breast cancer patients presenting to a tertiary hospital in Nigeria. J Clin Oncol 2021; 15: 1188.
Google Scholar13. Sapkota, B, Shrestha, R, Chapagai, S, et al. Validation of risk of chemotherapy-induced neutropenia: experience from oncology hospital of Nepal. Cancer Manag Res 2020; 12: 3751–3758.
Google Scholar | Crossref | Medline14. Lorenc, A, Ananthavarathan, P, Lorigan, J, et al. The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough. London J Prim Care (Abingdon) 2014; 6: 84–90.
Google Scholar | Crossref | Medline15. Alba-Loureiro, TC, Munhoz, CD, Martins, JO, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 2007; 40: 1037–1044.
Google Scholar | Crossref | Medline | ISI16. Mitroulis, I, Alexaki, VI, Kourtzelis, I, et al. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther 2015; 147: 123–135.
Google Scholar | Crossref | Medline17. Philip, ML, Saj, N, Sebastian, AM, et al. Assessment of chemotherapy-induced febrile neutropenia in cancer patients. Indian J Med Paediatr Oncol 2019; 40: 249.
Google Scholar | Crossref18. Hashiguchi, Y, Kasai, M, Fukuda, T, et al. Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy. Anticancer Drugs 2015; 26: 1054–1060.
Google Scholar | Crossref | Medline19. Fontanella, C, Bolzonello, S, Lederer, B, et al. Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia. Breast Care (Basel) 2014; 9: 239–245.
Google Scholar | Crossref | Medline20. Rapoport, BL, Aapro, M, Paesmans, M, et al. Febrile neutropenia (FN) occurrence outside of clinical trials: occurrence and predictive factors in adult patients treated with chemotherapy and an expected moderate FN risk. Rationale and design of a real-world prospective, observational, multinational study. BMC Cancer 2018; 18: 917.
Google Scholar | Medline21. Gradishar, WJ, Anderson, BO, Balassanian, R, et al. Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2016; 14: 324–354.
Google Scholar | Crossref | Medline | ISI